Compounds > amsacrine

amsacrine and Disease Models, Animal

amsacrine has been researched along with Disease Models, Animal in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Akaishi, T; Kokubun, T; Nakamura, M; Nakazawa, T; Omodaka, K; Sato, K; Saya, H; Shiga, Y; Shimazaki, A; Tsuda, S; Yamamoto, K1
Hagenbeek, A; Martens, AC1
Baguley, BC; Corbett, TH; Griswold, DP; Leopold, WR; Plowman, J1

Reviews

1 review(s) available for amsacrine and Disease Models, Animal

ArticleYear
DNA topoisomerase II inhibitors.
    IARC monographs on the evaluation of carcinogenic risks to humans, 2000, Volume: 76

    Topics: Amsacrine; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Etoposide; Evidence-Based Medicine; Humans; Intestinal Absorption; Mitoxantrone; Neoplasms; Nucleic Acid Synthesis Inhibitors; Research Design; Risk Factors; Teniposide; Tissue Distribution; Topoisomerase II Inhibitors

2000

Other Studies

5 other study(ies) available for amsacrine and Disease Models, Animal

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery.
    Scientific reports, 2019, 12-17, Volume: 9, Issue:1

    Topics: Amsacrine; Animals; Callithrix; Cicatrix; Conjunctiva; Disease Models, Animal; DNA Topoisomerases, Type II; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Primary Cell Culture; Topoisomerase II Inhibitors; Trabeculectomy

2019
AMSA: in vivo log cell kill for leukemic clonogenic cells versus toxicity for normal hemopoietic stem cells in a rat model for human acute myelocytic leukemia (BNML).
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:10

    Topics: Amsacrine; Animals; Clone Cells; Colony-Forming Units Assay; Disease Models, Animal; Hematopoietic Stem Cells; Humans; Lethal Dose 50; Leukemia, Myeloid, Acute; Rats

1986
Experimental antitumor activity of the amsacrine analogue CI-921.
    Journal of the National Cancer Institute, 1987, Volume: 79, Issue:2

    Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Line; Colonic Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains

1987